Opus Genetics, Inc. (IRD)
NASDAQ: IRD · Real-Time Price · USD
2.580
+0.290 (12.66%)
At close: Feb 5, 2026, 4:00 PM EST
2.599
+0.019 (0.74%)
After-hours: Feb 5, 2026, 7:59 PM EST
Opus Genetics Market Cap
Opus Genetics has a market cap or net worth of $177.93 million as of February 5, 2026. Its market cap has increased by 390.11% in one year.
Market Cap
177.93M
Enterprise Value
148.18M
1-Year Change
390.11%
Ranking
Category
Stock Price
$2.58
Market Cap Chart
Since November 6, 2020, Opus Genetics's market cap has increased from $21.26M to $177.93M, an increase of 736.81%. That is a compound annual growth rate of 49.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 4, 2026 | 157.93M | 13.93% |
| Dec 31, 2025 | 138.62M | 268.99% |
| Dec 31, 2024 | 37.57M | -44.87% |
| Dec 29, 2023 | 68.14M | -7.23% |
| Dec 30, 2022 | 73.45M | 13.82% |
| Dec 31, 2021 | 64.53M | -8.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 6, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Innate Pharma | 171.43M |
| Kalaris Therapeutics | 170.38M |
| Molecular Partners AG | 170.21M |
| Compugen | 169.30M |
| Prelude Therapeutics | 167.27M |
| ProQR Therapeutics | 163.29M |
| Zentalis Pharmaceuticals | 162.52M |
| Century Therapeutics | 160.83M |